Cipla's Financial Leap: Record Profits in Q3 2024
Cipla, a leading pharmaceutical company, reported a 48.73% increase in its consolidated net profit for the third quarter of 2024, reaching Rs 1,570.51 crore. This marks a significant rise from Rs 1,055.9 crore in the same period last year, with revenue climbing to Rs 7,072.97 crore.
![Cipla's Financial Leap: Record Profits in Q3 2024](https://devdiscourse.blob.core.windows.net/aiimagegallery/26_07_2024_10_59_32_6818819.png)
- Country:
- India
In a notable financial performance, pharmaceutical giant Cipla has reported a 48.73% increase in its consolidated net profit for the third quarter ending December 31, 2024, marking a significant rise to Rs 1,570.51 crore.
Comparatively, the company recorded a net profit of Rs 1,055.9 crore in the same period of the previous fiscal year, showcasing a substantial improvement in financial outcomes.
Additionally, Cipla's revenue from operations also demonstrated a positive trajectory, climbing to Rs 7,072.97 crore compared to Rs 6,603.81 crore last year. On the BSE, Cipla's shares ascended 4.28%, trading at Rs 1,455.70.
(With inputs from agencies.)
Advertisement
ALSO READ
Global Stock Markets Tumble Amid US Tariff Concerns
Indian Stock Market Boom: Household Participation Soars
Stock Markets Rally Amid Trade Optimism and Earnings Boost
Govt Issues Uniform Code for Ethical Pharmaceutical Marketing Practices 2024
Global Tensions Rattle Stock Markets: Vodafone and Diageo Drop Amid Trade Concerns